| The emerging role of regulatory cell-based therapy in autoimmune disease F Ghobadinezhad, N Ebrahimi, F Mozaffari, N Moradi, S Beiranvand, ... Frontiers in Immunology 13, 1075813, 2022 | 33 | 2022 |
| Engineered solid lipid nanoparticles and nanostructured lipid carriers as new generations of blood–brain barrier transmitters M Amiri, S Jafari, M Kurd, H Mohamadpour, M Khayati, F Ghobadinezhad, ... ACS Chemical Neuroscience 12 (24), 4475-4490, 2021 | 28 | 2021 |
| 3D bioprinting technology to mimic the tumor microenvironment: tumor-on-a-chip concept H Samadian, S Jafari, MR Sepand, L Alaei, SS Malvajerd, M Jaymand, ... Materials Today Advances 12, 100160, 2021 | 25 | 2021 |
| Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy M Babamohamadi, N Mohammadi, E Faryadi, M Haddadi, A Merati, ... Cell Death & Disease 15 (1), 17, 2024 | 12 | 2024 |
| Cellular conversations in glioblastoma progression, diagnosis and treatment AK Sisakht, M Malekan, F Ghobadinezhad, SNM Firouzabadi, A Jafari, ... Cellular and molecular neurobiology 43 (2), 585-603, 2023 | 12 | 2023 |
| circGFRA1: a circular RNA with important roles in human carcinogenesis S Khalilian, Z Mohajer, MAK Tabari, F Ghobadinezhad, S Ghafouri-Fard Pathology-Research and Practice 248, 154588, 2023 | 6 | 2023 |
| COVID-19 vaccine hesitancy worldwide and its associated factors: A systematic review and meta-analysis M Baghani, F Fathalizade, AH Loghman, N Samieefar, F Ghobadinezhad, ... Science in One Health, 100048, 2023 | 5 | 2023 |
| Adoptive cell transfer for solid tumors F Ghobadinezhad, Z Izadi, M Ebrahimi, N Rezaei | 1 | 2023 |
| Development and characterization of Polycaprolactone/chitosan-based scaffolds for tissue engineering of various organs: A review J Esmaeili, SZ Jalise, S Pisani, GY Rochefort, F Ghobadinezhad, ... International Journal of Biological Macromolecules, 132941, 2024 | | 2024 |
| Natural Killer Cells in Lung Cancer F Ghobadinezhad, Z Izadi, N Rezaei | | 2024 |
| Metabolic Pathways in Pediatric Cancers: Current Findings and Targets for Therapies F Salmanpour, D Alijanzadeh, F Ghobadinezhad, N Samieefar, M Piryaee, ... Handbook of Cancer and Immunology, 1-29, 2024 | | 2024 |
| Nature Killer T (NKT) Cells in Cancer F Ghobadinezhad, Z Izadi, M Ebrahimi, R Nima Handbook of Cancer and Immunology, 1-25, 2023 | | 2023 |
| Integrated Science 2050: Multidisciplinarity and Interdisciplinarity in Health N Rezaei, A Saghazadeh, ARI Ghani, AA Vedadhir, A Vahed, A Vellido, ... Multidisciplinarity and Interdisciplinarity in Health, 661-690, 2022 | | 2022 |
| Integrated, Multidisciplinary, and Interdisciplinary Medical Education N Samieefar, S Momtazmanesh, HD Ochs, T Ulrichs, V Roudenok, ... Multidisciplinarity and Interdisciplinarity in Health, 607-622, 2022 | | 2022 |
| Medicine: from scientific certainty to scientific humility F Ghobadinezhad, E Ranjbar, M Mohammadi | | |
| The lack of transparency and normalizing uncertainty E Ranjbar, M Mohammadi, F Ghobadinezhad | | |
Zhila IzadiAssistant professor,Department of Pharmaceutical Biomaterials, Faculty of PharmacyEmail verificata su razi.tums.ac.ir